International Stem Cell Corporation (ISCO)

USD 0.12

(20.0%)

Long Term Debt Summary of International Stem Cell Corporation

  • International Stem Cell Corporation's latest annual long term debt in 2023 was 445 Thousand USD , down -38.19% from previous year.
  • International Stem Cell Corporation's latest quarterly long term debt in 2024 Q1 was 367 Thousand USD , down 0.0% from previous quarter.
  • International Stem Cell Corporation reported annual long term debt of 720 Thousand USD in 2022, down -24.21% from previous year.
  • International Stem Cell Corporation reported annual long term debt of 950 Thousand USD in 2021, down -75.24% from previous year.
  • International Stem Cell Corporation reported quarterly long term debt of 286 Thousand USD for 2024 Q2, down 0.0% from previous quarter.
  • International Stem Cell Corporation reported quarterly long term debt of 445 Thousand USD for 2023 Q4, down -14.09% from previous quarter.

Annual Long Term Debt Chart of International Stem Cell Corporation (2023 - 2005)

Historical Annual Long Term Debt of International Stem Cell Corporation (2023 - 2005)

Year Long Term Debt Long Term Debt Growth
2023 445 Thousand USD -38.19%
2022 720 Thousand USD -24.21%
2021 950 Thousand USD -75.24%
2020 3.83 Million USD 24.26%
2019 3.08 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%

Peer Long Term Debt Comparison of International Stem Cell Corporation

Name Long Term Debt Long Term Debt Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Evofem Biosciences, Inc. 8000.00 USD -5462.5%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 74.651%
Qrons Inc. 80 Thousand USD -456.25%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 97.809%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. 171.23 Thousand USD -159.884%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 97.872%
Intellipharmaceutics International Inc. - USD -Infinity%
Propanc Biopharma, Inc. 58.64 Thousand USD -658.842%
Mesoblast Limited 100.29 Million USD 99.556%
Marizyme, Inc. 667.12 Thousand USD 33.296%
Genus plc 228.2 Million USD 99.805%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.732%
Therapeutic Solutions International, Inc. 5512.00 USD -7973.295%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 79.864%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 68.281%
IMV Inc. 27.39 Million USD 98.376%
AXIM Biotechnologies, Inc. 5.42 Million USD 91.799%
MultiCell Technologies, Inc. 36.43 USD -1221420.725%
ONE Bio Corp. 592.19 Thousand USD 24.856%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 99.2%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 80.009%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 63.773%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 19.761%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -1658.963%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD 76.56%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -38.199%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.996%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD -196.667%
Enzolytics Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD -171.003%
MetaStat, Inc. - USD -Infinity%
argenx SE 15.35 Million USD 97.102%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -9886.535%
Genscript Biotech Corporation 287.12 Million USD 99.845%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -252.33%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -94.077%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -93.739%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 94.615%
BioStem Technologies, Inc. 265.63 Thousand USD -67.523%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -41723.308%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -197.432%
Regen BioPharma, Inc. 149.61 Thousand USD -197.432%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -215.603%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 94.309%
SYBLEU INC 300 Thousand USD -48.333%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -20.58%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 94.54%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 2.626%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 61.671%
PureTech Health plc 18.25 Million USD 97.562%
Coeptis Therapeutics, Inc. 150 Thousand USD -196.667%
IXICO plc 275 Thousand USD -61.818%
IntelGenx Technologies Corp. 11.83 Million USD 96.241%
Gelesis Holdings, Inc. 26.3 Million USD 98.309%
CSL Limited 11.23 Billion USD 99.996%
Cellectis S.A. 36.21 Million USD 98.771%